Skip to content
PubMed This is a summary of 63 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 63 referenced papers

Top Authors

Gulab Zode
University of California, Irvine
W. Daniel Stamer
Duke Medical Center
Abbot F. Clark
Alcon (United States)
Surinder Singh Pandav
National Eye Centre
Ramesh B. Kasetti
University of North Texas
Sonia Phulke
Post Graduate Institute of Medical Education and Research
Shaohai Jiang
National University of Singapore
Kate E. Keller
Oregon Health & Science University
Davinder S. Grover
Glaucoma Associates of Texas
Darryl R. Overby
Imperial College London

Top Institutions

Ranked by publications Top 10 institutions
04

Post Graduate Institute of Medical Education and Research

Chandigarh, India

11 papers

References

References (63)
  1. 1

    Animal models of glucocorticoid-induced glaucoma.

    Overby DR, Clark AF

    Experimental eye research 2015; (141()):15-22.

    PMID: 26051991
  2. 2

    Goniotomy for Steroid-Induced Glaucoma: Clinical and Tonographic Evidence to Support Therapeutic Goniotomy.

    Choi EY, Walton DS

    Journal of pediatric ophthalmology and strabismus 2015; (52(3)):183-8 doi:10.3928/01913913-20150427-05.

    PMID: 26053210
  3. 3

    Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex®) on intraocular pressure in patients with macular edema.

    Mazzarella S, Mateo C, Freixes S, et al.

    Ophthalmic research 2015; (54(3)):143-9 doi:10.1159/000438759.

    PMID: 26394206
  4. 4

    Current Approach in the Diagnosis and Management of Uveitic Glaucoma.

    Muñoz-Negrete FJ, Moreno-Montañés J, Hernández-Martínez P, Rebolleda G

    BioMed research international 2015; (2015()):742792 doi:10.1155/2015/742792.

    PMID: 26558280
  5. 5

    Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.

    Chan LW, Hsu WC, Hsieh YT

    Journal of glaucoma 2016; (25(3)):e268-72 doi:10.1097/IJG.0000000000000296.

    PMID: 26950466
  6. 6

    Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.

    Sheppard JD, Comstock TL, Cavet ME

    Advances in therapy 2016; (33(4)):532-52 doi:10.1007/s12325-016-0315-8.

    PMID: 26984315
  7. 7

    Risk Factors and the Incidence of Ocular Hypertension After Penetrating Keratoplasty.

    Orucoglu F, Blumenthal EZ, Frucht-Pery J, Solomon A

    Journal of glaucoma 2016; (25(7)):e725 doi:10.1097/IJG.0000000000000416.

    PMID: 27027229
  8. 8

    Expression of Mutant Myocilin Induces Abnormal Intracellular Accumulation of Selected Extracellular Matrix Proteins in the Trabecular Meshwork.

    Kasetti RB, Phan TN, Millar JC, Zode GS

    Investigative ophthalmology & visual science 2016; (57(14)):6058-6069 doi:10.1167/iovs.16-19610.

    PMID: 27820874
  9. 9

    Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells.

    Li G, Cui G, Dismuke WM, et al.

    Experimental eye research 2017; (155()):38-46 doi:10.1016/j.exer.2016.12.002.

    PMID: 27939447
  10. 10

    Steroid-induced glaucoma in the pediatric population.

    Nuyen B, Weinreb RN, Robbins SL

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2017; (21(1)):1-6 doi:10.1016/j.jaapos.2016.09.026.

    PMID: 28087345
  11. 11

    Steroid-induced Glaucoma: An Avoidable Irreversible Blindness.

    Phulke S, Kaushik S, Kaur S, Pandav SS

    Journal of current glaucoma practice 2017; (11(2)):67-72 doi:10.5005/jp-journals-l0028-1226.

    PMID: 28924342
  12. 12

    Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork.

    Kasetti RB, Maddineni P, Millar JC, et al.

    Scientific reports 2017; (7(1)):14951 doi:10.1038/s41598-017-14938-0.

    PMID: 29097767
  13. 13

    Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.

    Kasetti RB, Maddineni P, Patel PD, et al.

    The Journal of biological chemistry 2018; (293(25)):9854-9868 doi:10.1074/jbc.RA118.002540.

    PMID: 29743238
  14. 14

    Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant.

    Pérez-Sarriegui A, Casas-Llera P, Díez-Álvarez L, et al.

    Archivos de la Sociedad Espanola de Oftalmologia 2018; (93(12)):580-585 doi:10.1016/j.oftal.2018.06.011.

    PMID: 30266279
  15. 15

    The Genetic Influence on Corticosteroid-Induced Ocular Hypertension: A Field Positioned for Discovery.

    Chan W, Wiggs JL, Sobrin L

    American journal of ophthalmology 2019; (202()):1-5 doi:10.1016/j.ajo.2019.02.001.

    PMID: 30763540
  16. 16

    Case series of children with steroid-Induced glaucoma.

    Lam CS, Umi Kalthum MN, Norshamsiah MD, Bastion M

    Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia 2018; (13(3)):32-37.

    PMID: 30800232
  17. 17

    [Perioperative/Postoperative Anti-Inflammatory Therapy During/After Corneal Surgery/Transplantation].

    Bachmann BO, Pleyer U, Maier PC, et al.

    Klinische Monatsblatter fur Augenheilkunde 2019; (236(5)):653-661 doi:10.1055/a-0864-4793.

    PMID: 31096284
  18. 18

    Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis.

    Beverstock A, Kelly A

    BMJ case reports 2019; (12(5)) doi:10.1136/bcr-2019-229803.

    PMID: 31129643
  19. 19

    Gonioscopy-assisted Transluminal Trabeculotomy (GATT) is An Effective Procedure for Steroid-induced Glaucoma.

    Boese EA, Shah M

    Journal of glaucoma 2019; (28(9)):803-807 doi:10.1097/IJG.0000000000001317.

    PMID: 31259756
  20. 20

    Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery.

    Sheppard JD, Singh IP

    Clinical ophthalmology (Auckland, N.Z.) 2019; (13()):1279-1288 doi:10.2147/OPTH.S206424.

    PMID: 31409967
  21. 21

    Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study.

    Prasad D, Poddar U, Kanaujia V, et al.

    Journal of glaucoma 2019; (28(10)):929-933 doi:10.1097/IJG.0000000000001352.

    PMID: 31453897
  22. 22

    Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group.

    Sen P, Jain S, Mohan A, et al.

    Indian journal of ophthalmology 2019; (67(10)):1650-1655 doi:10.4103/ijo.IJO_2143_18.

    PMID: 31546501
  23. 23

    Gonioscopy-assisted Transluminal Trabeculotomy in a Pediatric Patient With Steroid-induced Glaucoma.

    Hopen ML, Gallardo MJ, Grover D

    Journal of glaucoma 2019; (28(10)):e156-e158 doi:10.1097/IJG.0000000000001326.

    PMID: 31574020
  24. 24

    Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis.

    Xiao J, Zhao C, Liang A, et al.

    Ocular immunology and inflammation 2021; (29(4)):766-770 doi:10.1080/09273948.2019.1687730.

    PMID: 31902258
  25. 25

    Intra-articular spine injections of steroid as a contributing factor to glaucoma.

    Qin Q, Casson RJ, Myers D, Cugati S

    Clinical & experimental ophthalmology 2020; (48(5)):703-705 doi:10.1111/ceo.13735.

    PMID: 32083765
  26. 26

    The Molecular Processes in the Trabecular Meshwork After Exposure to Corticosteroids and in Corticosteroid-Induced Ocular Hypertension.

    Liesenborghs I, Eijssen LMT, Kutmon M, et al.

    Investigative ophthalmology & visual science 2020; (61(4)):24 doi:10.1167/iovs.61.4.24.

    PMID: 32305042
  27. 27

    [Drug-induced glaucoma].

    Ostroumova OD, Shikh EV, Rebrova EV, et al.

    Vestnik oftalmologii 2020; (136(2)):107-116 doi:10.17116/oftalma2020136021107.

    PMID: 32366078
  28. 28

    Impact of Visual Field Testing on Intraocular Pressure Change Trends in Healthy People and Glaucoma Patients.

    Li M, Zheng B, Wang Q, Sun X

    Journal of ophthalmology 2020; (2020()):7936205 doi:10.1155/2020/7936205.

    PMID: 32714610
  29. 29

    Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient.

    David RL, Sen P

    Oman journal of ophthalmology 2020; (13(2)):92-94 doi:10.4103/ojo.OJO_40_2018.

    PMID: 32792805
  30. 30

    Effects of Netarsudil on Actin-Driven Cellular Functions in Normal and Glaucomatous Trabecular Meshwork Cells: A Live Imaging Study.

    Keller KE, Kopczynski C

    Journal of clinical medicine 2020; (9(11)) doi:10.3390/jcm9113524.

    PMID: 33142742
  31. 31

    Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study.

    Pacella E, Loffredo L, Malvasi M, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):3611-3617 doi:10.2147/OPTH.S265691.

    PMID: 33154620
  32. 32

    Risk of ocular hypertension in children treated with systemic glucocorticoid.

    Krag S, Larsen D, Albertsen BK, Glerup M

    Acta ophthalmologica 2021; (99(8)):e1430-e1434 doi:10.1111/aos.14820.

    PMID: 33629533
  33. 33

    Aetiology and clinical characteristics of uveitic glaucoma in Turkish patients.

    Altan C, Basarir B

    International ophthalmology 2021; (41(6)):2225-2234 doi:10.1007/s10792-021-01783-4.

    PMID: 33730317
  34. 34

    Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis.

    Li G, Lee C, Read AT, et al.

    eLife 2021; (10()).

    PMID: 33783352
  35. 35

    Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma.

    AlObaida I, Al Owaifeer AM, Alotaibi H, et al.

    European journal of ophthalmology 2022; (32(3)):1525-1529 doi:10.1177/11206721211023310.

    PMID: 34096363
  36. 36

    Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma.

    Zhou Y, Pruet CM, Fang C, Khanna CL

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2022; (57(4)):277-283 doi:10.1016/j.jcjo.2021.05.006.

    PMID: 34119463
  37. 37

    Elevated intraocular pressure in children with acute lymphoblastic leukaemia: A prospective study.

    Barzilai-Birenboim S, Elitzur S, Nirel R, et al.

    British journal of haematology 2022; (196(5)):1248-1256 doi:10.1111/bjh.17987.

    PMID: 34862597
  38. 38

    Steroid-Induced Ocular Hypertension in a Pediatric Patient with Acute Lymphoblastic Leukemia: A Case Report.

    Lai HY, Lai IC, Fang PC, et al.

    Children (Basel, Switzerland) 2022; (9(3)) doi:10.3390/children9030440.

    PMID: 35327812
  39. 39

    Risk of Elevated Intraocular Pressure With Difluprednate in Patients With Non-Infectious Uveitis.

    Yakin M, Kumar A, Kodati S, et al.

    American journal of ophthalmology 2022; (240()):232-238 doi:10.1016/j.ajo.2022.03.026.

    PMID: 35381204
  40. 40

    The short-term effects of intranasal steroids on intraocular pressure in pediatric population.

    Ozturk T, Durmaz Engin C, Koksaldi S, Arikan G

    International ophthalmology 2022; (42(12)):3821-3827 doi:10.1007/s10792-022-02402-6.

    PMID: 35819739
  41. 41

    [XEN 45® gel stent implantation in glaucoma surgery: Dual-center comparative study between steroid-induced glaucoma and primary open angle glaucoma].

    Cornée C, Orignac I, Wargny M, et al.

    Journal francais d'ophtalmologie 2022; (45(8)):872-882 doi:10.1016/j.jfo.2022.04.007.

    PMID: 35906134
  42. 42

    Axial Length as a Risk Factor for Steroid-Induced Ocular Hypertension.

    Choi W, Kim JD, Bae HW, et al.

    Yonsei medical journal 2022; (63(9)):850-855 doi:10.3349/ymj.2022.63.9.850.

    PMID: 36031785
  43. 43

    Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report.

    Rezkallah A, Loria O, Mathis T, et al.

    Case reports in ophthalmology 2022; (13(3)):1024-1029 doi:10.1159/000527672.

    PMID: 36605048
  44. 44

    Intraocular Pressure Elevation After Posterior Subtenon Triamcinolone Acetonide Injection in Pediatric Non-Infectious Uveitis.

    Yalcinsoy KO, Ozdal PC, Sen E, Elgin U

    Beyoglu eye journal 2022; (7(4)):298-303 doi:10.14744/bej.2022.97752.

    PMID: 36628084
  45. 45

    Gonioscopy-Assisted Transluminal Trabeculotomy and Goniotomy, With or Without Concomitant Cataract Extraction, in Steroid-Induced and Uveitic Glaucoma: 24-Month Outcomes.

    Chen RI, Purgert R, Eisengart J

    Journal of glaucoma 2023; (32(6)):501-510 doi:10.1097/IJG.0000000000002183.

    PMID: 36795532
  46. 46

    Long-Term Risk of Steroid-Induced Ocular Hypertension/Glaucoma With Topical Prednisolone Acetate 1% After Descemet Stripping Endothelial Keratoplasty.

    Price MO, Price DA, Price FW

    Cornea 2024; (43(3)):323-326 doi:10.1097/ICO.0000000000003312.

    PMID: 37155339
  47. 47

    Steroid-induced glaucoma: an avoidable cause of irreversible blindness.

    Teo BHK, Au Eong JTW, Au Eong KG

    BMJ case reports 2023; (16(9)) doi:10.1136/bcr-2023-254709.

    PMID: 37666571
  48. 48

    The Effects of ROCK Inhibitor on Prevention of Dexamethasone-Induced Glaucoma Phenotype in Human Trabecular Meshwork Cells.

    Debele TA, Mount ZF, Yuan Y, et al.

    Translational vision science & technology 2023; (12(12)):4 doi:10.1167/tvst.12.12.4.

    PMID: 38051267
  49. 49

    Level of empowerment of hospitalized patient in Taiwan clinical practice.

    Yeh MY, Wu SM, Che HL

    Journal of the Formosan Medical Association = Taiwan yi zhi 2024; (123(11)):1139-1143 doi:10.1016/j.jfma.2024.07.007.

    PMID: 38977388
  50. 50

    CYP3A4 Poor and Intermediate Metabolizers Have a Higher Rate of Steroid-Induced Intraocular Pressure Response.

    Wright JA, Xu SC, Wong MH, et al.

    Journal of glaucoma 2025; (34(2)):e9-e12 doi:10.1097/IJG.0000000000002482.

    PMID: 39133066
  51. 51

    Oral Cyclosporine in Vernal Keratoconjunctivitis: Indications, Outcomes, and Effect on Corticosteroid Use.

    Kate A, Tallapelly HG, Jain N, et al.

    Cornea 2025; (44(9)):1078-1083 doi:10.1097/ICO.0000000000003786.

    PMID: 39791868
  52. 52

    Steroid-induced glaucoma in kidney transplant recipients: a prospective cross-sectional study.

    Jain VK, Agarwal R, Maroof L, et al.

    Romanian journal of ophthalmology 2024; (68(4)):362-366 doi:10.22336/rjo.2024.66.

    PMID: 39936059
  53. 53

    Managing Bilateral Vernal Keratoconjunctivitis, Keratoconus, and Steroid-Induced Glaucoma: A Threefold Struggle.

    Maffar NH, Azhany Y, Mohd Ghazali NAS, Muhammed J

    Cureus 2025; (17(1)):e77901 doi:10.7759/cureus.77901.

    PMID: 39991424
  54. 54

    Differences of patient empowerment between elective and contracted physicians in internal medicine in Austria: a quantitative content analysis.

    Simetsberger B, Pferzinger M, Waiguny MKJ

    BMC health services research 2025; (25(1)):476 doi:10.1186/s12913-025-12635-7.

    PMID: 40165195
  55. 55

    Incidence and risk factors of ocular hypertension following ıntravitreal dexamethasone implantation: the role of baseline intraocular pressure.

    Ertan E, Çelen İ, Gül C

    International ophthalmology 2025; (45(1)):233 doi:10.1007/s10792-025-03605-3.

    PMID: 40478293
  56. 56

    Characterizing the expression profile of Dexras1 in human trabecular meshwork cells.

    Chen C, Han J, Sanchez L, et al.

    Biochemistry and biophysics reports 2025; (43()):102077 doi:10.1016/j.bbrep.2025.102077.

    PMID: 40546349
  57. 57

    Gonioscopy-assisted transluminal trabeculotomy for intractable ocular hypertension after repeated intravitreal dexamethasone implant injections.

    Ucgul RK, Olgun AO, Akdeniz ZB, et al.

    International ophthalmology 2025; (45(1)):325 doi:10.1007/s10792-025-03698-w.

    PMID: 40773070
  58. 58

    Uveitic Glaucoma Interest Group Recommendations for Uveitis-Related Ocular Hypertension and Glaucoma Management.

    Pantcheva MB, Gangaputra S, Sieck E, et al.

    Ocular immunology and inflammation 2025; (33(9)):2153-2167 doi:10.1080/09273948.2025.2542286.

    PMID: 40971800
  59. 59

    Unlocking potential: impact of mHealth affordance realization on patient well-being.

    Dantu R, Murad MMI

    Journal of health organization and management 2026; (40(5)):896-921 doi:10.1108/JHOM-03-2025-0133.

    PMID: 41144430
  60. 60

    Team-based approach to fibromuscular dysplasia.

    Rao SJ, Kim ESH, Mitromaras C, et al.

    Seminars in vascular surgery 2025; (38(4)):395-403 doi:10.1053/j.semvascsurg.2025.10.001.

    PMID: 41386914
  61. 61

    Multifunctional Online Medical Record Use and Patient Empowerment: Examining the Mediating Role of Patient-Centered Communication Across the Life Span in the Greater China Region.

    Ye JF, Zheng S, Liu PL

    Health communication 2026; 1-13 doi:10.1080/10410236.2026.2668013.

    PMID: 42083334
  62. 62

    Outcomes of Minimally Invasive Glaucoma Surgery, Trabeculectomy, and Tube Shunt Surgery in Secondary Glaucoma: IRIS® Registry Analysis.

    Fujita A, Zebardast N, Lorch AC, et al.

    American journal of ophthalmology 2026; (289()):7-19 doi:10.1016/j.ajo.2026.05.011.

    PMID: 42140464
  63. 63

    Prognostic value of applanation tonometry, pachymetry and automated perimetry in monitoring glaucoma progression: A longitudinal analytical study.

    Pandey S, Upadhyay K, Jain S, et al.

    Bioinformation 2026; (22(4)):2244-2248 doi:10.6026/973206300222244.

    PMID: 42282323